Transient drop in the neutrophil count during COVID-19 regardless of clozapine treatment in patients with mental illness
- 1 April 2022
- journal article
- letter
- Published by Elsevier BV in Revista de Psiquiatría y Salud Mental
- Vol. 15 (2), 134-137
- https://doi.org/10.1016/j.rpsm.2021.06.002
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- COVID‐19 and the clinical hematology laboratoryInternational Journal of Laboratory Hematology, 2020
- Hematological findings and complications of COVID‐19American Journal of Hematology, 2020
- Consensus statement on the use of clozapine during the COVID-19 pandemicJournal of Psychiatry and Neuroscience, 2020
- Consensus statement on the use of clozapine during the COVID-19 pandemic2020
- Isolated Chronic and Transient Neutropenia
Cureus, 2019
- Elevated clozapine levels associated with infection: A systematic reviewSchizophrenia Research, 2018
- Non–chemotherapy drug–induced neutropenia: key points to manage the challengesHematology, 2017
- Clozapinev. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysisThe British Journal of Psychiatry, 2016
- How we diagnose and treat neutropenia in adultsExpert Review of Hematology, 2016
- Neutrophils in viral infections: Current concepts and caveatsJournal of Leukocyte Biology, 2015